StrataGraft Topical Burn Treatment Gets US FDA Approval

The topical treatment is made from human skin cells and can be applied to speed the healing of deep thermal burns.

FDA building

A topical burn treatment from Mallinckrodt plc division Stratatech Corporation has been approved by the US Food and Drug Administration.

StrataGraft is indicated to treat adults with thermal burns in which some deep skin layers remain intact, also known as deep partial thickness burns. The therapy is produced from two...

More from Approvals

More from Policy & Regulation

EU Finalizes Framework For Joint Clinical Assessments Of High-Risk Devices

 

Second submission window for joint scientific consultations on a procedure to help prepare for joint clinical assessments will open from 2 to 30 June 2025.

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.

UK Take Care! Regulatory And Market Access Reforms Must Not Shut Out Medtech Growth

 
• By 

Speakers at a recent UK medtech outlook conference voiced optimism about the sector’s prospects, but warned that cost burdens, over-regulation and lengthy processes will impede the capacity of local SMEs to innovate. Only 10% of NHS procured medtech comes from UK manufacturers.